Related Experiment Video
Updated: Jan 20, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
Identification of Compounds That Interfere with High-Throughput Screening Assay Technologies
Laurianne David1,2, Jarrod Walsh3, Noé Sturm4
1Hit Discovery, Discovery Sciences, R&D BioPharmaceuticals, AstraZeneca Goteborg, Pepparedsleden 1, 431 83, Mölndal, Sweden.
Abstract:
A significant challenge in high-throughput screening (HTS) campaigns is the identification of assay technology interference compounds. A Compound Interfering with an Assay Technology (CIAT) gives false readouts in many assays. CIATs are often considered viable hits and investigated in follow-up studies, thus impeding research and wasting resources. In this study, we developed a machine-learning (ML) model to predict CIATs for three assay technologies. The model was trained on known CIATs and non-CIATs (NCIATs) identified in artefact assays and described by their 2D structural descriptors. Usual methods identifying CIATs are based on statistical analysis of historical primary screening data and do not consider experimental assays identifying CIATs. Our results show successful prediction of CIATs for existing and novel compounds and provide a complementary and wider set of predicted CIATs compared to BSF, a published structure-independent model, and to the PAINS substructural filters. Our analysis is an example of how well-curated datasets can provide powerful predictive models despite their relatively small size.
More Related Videos
Related Concept Videos
09:44High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
07:50Assay Development for High-Throughput Drug Screening Against Mycobacteria
13:59High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
11:13Identification of Kinase-substrate Pairs Using High Throughput Screening
06:19High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography
07:39SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

